Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Molecular Templates Inc

MTEM
1,28
-0,12 (-8,57%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202414:13EDGAR2Form 8-K - Current report
03/6/202414:11GLOBEMolecular Templates, Inc. Provides Interim Update
15/5/202423:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202423:18EDGAR2Form 8-K - Current report
15/5/202423:11GLOBEMolecular Templates, Inc. Reports First Quarter 2024..
09/4/202414:11GLOBEMolecular Templates Presents Interim Data from MT-6402 Phase..
29/3/202413:21GLOBEMolecular Templates, Inc. Reports Fourth Quarter 2023..
28/3/202413:11GLOBEMolecular Templates Announces $9.5 Million Private Placement..
04/3/202414:11GLOBEMolecular Templates, Inc. Provides Interim Update
15/2/202402:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:55GLOBEMolecular Templates to Present at Oppenheimer 34th Annual..
25/1/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:04EDGAR2Form 8-K - Current report
13/11/202322:13EDGAR2Form 8-K - Current report
13/11/202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:11GLOBEMolecular Templates, Inc. Reports Third Quarter 2023..
02/11/202321:11GLOBEMolecular Templates Announces First Patient Dosed in Phase 1..
01/11/202321:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:12GLOBEMolecular Templates to Participate in Upcoming Investor..
31/10/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202322:12EDGAR2Form 8-K - Current report
06/10/202323:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/9/202323:01EDGAR2Form 8-K - Current report
28/9/202322:11GLOBEMolecular Templates Announces the Appointment of Dr...
12/9/202323:15EDGAR2Form ARS - Annual Report to Security Holders
12/9/202323:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202323:08EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202300:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202322:11EDGAR2Form 8-K - Current report
11/8/202322:12EDGAR2Form 8-K - Current report
11/8/202317:22GLOBEMolecular Templates Announces 1-for-15 Reverse Stock Split
10/8/202315:01EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202314:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:09EDGAR2Form 8-K - Current report
10/8/202314:08GLOBEMolecular Templates, Inc. Reports Second Quarter 2023..
02/8/202322:16EDGAR2Form 8-K - Current report
02/8/202322:11GLOBEMolecular Templates Announces Executive Leadership Changes
18/7/202317:56EDGAR2Form DEF 14A - Other definitive proxy statements
13/7/202318:48EDGAR2Form 8-K - Current report
13/7/202314:14GLOBEMolecular Templates Announces Up to $40 Million Private..
30/6/202322:31EDGAR2Form PRE 14A - Other preliminary proxy statements
17/6/202302:56GLOBEMolecular Templates Announces Debt Payoff and Restructuring
Apertura: 1,34 Min: 1,25 Max: 1,40
Chiusura: 1,40

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network